# A Study of TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver Transplantation

> **NCT02719782** · PHASE1 · UNKNOWN · sponsor: **Lion TCR Pte. Ltd.** · enrollment: 10 (estimated)

## Conditions studied

- Recurrent Hepatocellular Carcinoma

## Interventions

- **BIOLOGICAL:** Biological: TCR-T

## Key facts

- **NCT ID:** NCT02719782
- **Lead sponsor:** Lion TCR Pte. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07-02
- **Primary completion:** 2019-05
- **Final completion:** 2019-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2018-11-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02719782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02719782, "A Study of TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver Transplantation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02719782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*